Hemophilia: Difference between revisions
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
*ICH is most common cause of hemorrhagic death | *ICH is most common cause of hemorrhagic death | ||
*Do not give NSAIDs or IM injections | *Do not give NSAIDs or IM injections | ||
*Avoid invasive procedures (e.g. central lines, LP (unless give factor replacement therapy)) | *Avoid invasive procedures (e.g. central lines, LP (unless give factor replacement therapy)) | ||
*Consult hematology if pt has h/o inhibitors | *Consult hematology if pt has h/o inhibitors | ||
== Clinical Features == | == Clinical Features == | ||
#Hemarthroses | #Hemarthroses | ||
| Line 50: | Line 50: | ||
== Treatment == | == Treatment == | ||
=== Factor Replacement === | === Factor Replacement === | ||
*Major bleeding (GI, CNS, large muscle, trauma)requires factor replacement levels 80-100% | |||
*Moderate bleeding (soft tissue, small muscle, joint) requires 30-50% | |||
*FFP if diagnosis is unknown (contains VIII and IX) | *FFP if diagnosis is unknown (contains VIII and IX) | ||
| Line 62: | Line 64: | ||
***1 IU/kg will increase the plasma concentration by 1% | ***1 IU/kg will increase the plasma concentration by 1% | ||
=== Specific Therapy (Factor VIII) === | === Specific Therapy (Factor VIII) === | ||
{| border="1" cellpadding="2" | {| border="1" cellpadding="2" | ||
| Line 83: | Line 85: | ||
| align="left" | Local pressure and anesthetic with epinephrine may benefit; watch 4 hours after suturing; reexamine in 24 hours | | align="left" | Local pressure and anesthetic with epinephrine may benefit; watch 4 hours after suturing; reexamine in 24 hours | ||
|- | |- | ||
| align="left" | <br> | | align="left" | <br> | ||
| align="left" | <br> | | align="left" | <br> | ||
| align="left" | <br> | | align="left" | <br> | ||
| Line 93: | Line 95: | ||
| align="left" | May need hospitalization for observation; repeat may be necessary for suture removal | | align="left" | May need hospitalization for observation; repeat may be necessary for suture removal | ||
|- | |- | ||
| align="left" | '''EPISTAXIS''' | | align="left" | '''EPISTAXIS''' | ||
| align="left" | <br> | | align="left" | <br> | ||
| align="left" | <br> | | align="left" | <br> | ||
Revision as of 02:39, 13 October 2011
Background
- Two types (clinically indistinguishable):
- Hemophilia A: Factor VIII deficiency
- Hemophilia B: Factor IX deficiency
- Substantial proportion of both types arise from spontaneous mutations
- X-linked disorders (overwhelmingly a disease of men)
- ICH is most common cause of hemorrhagic death
- Do not give NSAIDs or IM injections
- Avoid invasive procedures (e.g. central lines, LP (unless give factor replacement therapy))
- Consult hematology if pt has h/o inhibitors
Clinical Features
- Hemarthroses
- Leads to joint destruction and chronic arthropathy if not adequately treated
- Pts can reliably report when bleeding is occurring
- Hematomas
- Bleeding into soft tissues or muscle
- Neck (airway compromise)
- Limbs (compartment syndromes)
- Eye (retro-orbital hematoma)
- Spine (epidural hematoma)
- Retroperitoneum (iliopsoas bleeds and massive blood loss)
- Bleeding into soft tissues or muscle
- Mucocutaneous bleeding
- Spontaneous bleeding uncommon from oropharynx, GI tract, epistaxis, or hemoptysis
- CNS
- Intracranial bleeding is most common cause of hemorrhagic death
- Subdural hematomas occur spontaneously or with minimal trauma
- Hematuria
- Common, usually not serious, source is rarely found
Diagnosis
- Easy bruising or bleeding out of proportion to the history of trauma
- Recurrent bleeding into joints and muscles
- Prolonged PTT; normal PT
Work-Up
- Coags
- Only helpful for making the dx; once established unlikely to yield new information
- PT - normal
- PTT - abnormal (unless mild hemophilia)
- Head CT
- If c/o HA, AMS, significant blunt head injury
- CT A/P
- Back, thigh, groin, or abd pain
Treatment
Factor Replacement
- Major bleeding (GI, CNS, large muscle, trauma)requires factor replacement levels 80-100%
- Moderate bleeding (soft tissue, small muscle, joint) requires 30-50%
- FFP if diagnosis is unknown (contains VIII and IX)
- Each bag raises factor levels by 3-5%
- Factor replacement if diagnosis is known
- Dose of Factor VIII = weight (kg) x % increased desired x 0.5
- After initial correction give half this dose q8-12hr
- 1 IU/kg will increase the plasma concentration by 2%
- Dose of Factor IX = weight (kg) x % increase desired
- After initial correction give half this dose 24 hr later
- 1 IU/kg will increase the plasma concentration by 1%
- Dose of Factor VIII = weight (kg) x % increased desired x 0.5
Specific Therapy (Factor VIII)
| TYPE OF BLEEDING | INITIAL DOSAGE | DURATION | COMMENT |
|---|---|---|---|
| SKIN | |||
| Abrasion | None | None | Treat with local pressure and topical thrombin |
| Laceration | Usually none; if necessary, treat as minor | None | Local pressure and anesthetic with epinephrine may benefit; watch 4 hours after suturing; reexamine in 24 hours |
| Deep | Minor bleeding (12.5 mg/kg) | Single-dose coverage | May need hospitalization for observation; repeat may be necessary for suture removal |
| EPISTAXIS | |||
| Spontaneous | Usually none; may need to be treated as mild bleeding | None | Uncommon; consider platelet inhibition; treat in usual manner |
| Traumatic | Moderate bleeding (25 mg/kg) | Up to 5–7 days | Trauma-related bleeding can be significant |
| ORAL | |||
| Mucosa or tongue bites | Usually none; treat as minor if persists | Single dose | Commonly seen |
| Traumatic (laceration) or dental extraction | Moderate (25 U/kg) to severe (50 U/kg) | Single dose; may need more | Saliva rich in fibrin lytic activity; oral ε-aminocaproic acid (Amicar) may be given at 100 mg every 6 hr for 7 days to block fibrinolysis; check contraindications; hospitalize patients with severe bleeding |
| Soft tissue/muscle hematomas | Moderate (25 U/kg) to severe (50 U/kg) | 2–5 days | May be complicated by local pressure on nerves or vessels (e.g., iliopsoas, forearm, calf) |
| Hemarthrosis | |||
| Early | Mild (12.5 U/kg) | Single dose | Treat as earliest symptom (pain); knee, elbow, ankle more common |
| Late or unresponsive cases of early hemarthrosis | Mild to moderate (25 U/kg) | 3–4 days | Arthrocentesis rarely necessary and only with 50% level coverage; immobilization is critical point of therapy |
| Hematuria | Mild (12.5 U/kg) | 2–3 days | Urokinase, the fibrinolytic enzyme, is in urine; with persistent hematuria an organic cause should be ruled out |
| Major Bleeding | Major bleeding (50 U/kg) | 7–10 days or 3–5 days after bleeding ceases | In head trauma, therapy should be given prophylactically; early CT scan of head recommended for all |
Source
- Tintinalli
- Rosen's
